Newsletter registration

By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Ideas know no boundaries.
Herta Steinkellner develops tobacco plants for the fight against the Ebola.

Life Sciences Cluster in Austria

Innovation optimally thrives in creative, interdisciplinary ecosystems. Diversity and strong networking have always characterized the Austrian life sciences community. Top researchers and “serial entrepreneurs” work side by side, whereas companies and intellectual property come together via idea portals. Clusters and competence centers with regional priorities in red, green and white biotechnology promote a lively cooperation between science and business, university-level and non-university research.

LISAvienna

Vienna not only offers the best quality of life around the world, but has also established itself as an international location for life sciences. About 480 companies in this sector operate mainly in the fields of biotechnology, pharmaceuticals and medical technology, including well-known multinationals such as Baxalta, Boehringer Ingelheim, Novartis and Ottobock. They generated revenue surpassing EUR 10 billion in 2014, employing a workforce of 35.730 people. They are complemented by 14,000 highly qualified specialized staff at 25 research facilities in the Austrian capital city. LISAvienna supports innovative companies to develop new products, services and processes and launch them on the marketplace. The platform networks companies, linking them with development partners and key customers.

Life Sciences Tirol

74 innovative companies boasting more than 23,000 qualified employees and offering product and service solutions in life sciences are linked via the Life Sciences Cluster Tirol in the west of Austria. Entrepreneurial success is ensured based on the good cooperation with international universities such as the Munich University of Technology and non-university research institutes, Oncotyrol, the Competence Center for Personalized Cancer Medicine and Bioindustry Park Canavese.

Human.Technology.Styria GmbH

The focus in Styria is on “white biotechnology”. Some 80 partner organizations of the human technology cluster focus on three areas of competence: pharmaceutical process and production technologies, biomedical sensor technologies and biomechanics as well as biobanking and biomarker technologies. The partners of Human.Technology.Styria have won international recognition, including the “International Innovation Prize 2014” for the “Enzyme Google”. A patent application was filed for the “Catalophor system” developed by acib as described in the scientific journal “Nature Communications”.

Technopol Krems

This Lower Austrian hotspot for medical biotechnology not only carries out cancer research but groundbreaking research on blood purification procedures, artificial joints and cartilage and the healing of chronic injuries. The focus of Technopol Krems is on biomedicine (tissue engineering, cell therapies, extracorporeal blood purification) and health sciences.

Medical Technology Cluster Upper Austria

The Medical Technology Cluster Upper Austria, a network for this industry, supports medical and health care technology companies. The cluster has 217 members with 37,500 employees.

 

Please find more information on Life Sciences in Austria here.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Üzlet Ausztriában konzultációs nap

    18.09.2019 / 14:00 - 17:00, Debrecen, Hungary

Austria Map

Find the perfect location for your company

Inspite of higher labor costs, the productivity of Siemens Villach is comparable to other Siemens susidiaries in Japan or the USA.

Siemens Austria

Logo
More testimonials

news from the business location Austria

Pfizer builds international quality control centre in Austria

A total of EUR 50 million is being invested in the construction of a new laboratory for an international quality control centre for vaccines, as well as the construction of modern office space and the modernisation and expansion of the existing infrastructure for vaccine production.

Austrian SMEs Implement Measures to Curb Climate Change

Drought, storms, floods and mass immigration: climate change is real, and its consequences will pose massive challenges to society, political decision makers and the economy. This text focuses on how Austrian SMEs face the effects of climate change and why the changes also open up economic opportunities.

More news All blog posts